Form D · Other
Barking Labs Corp.
Brooklyn, NY · CIK 0001731618
Offering snapshot reported Mar 2, 2021 · SEC filing
- Reported sold
- $29.5M Offering amount: $29.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 2, 2021 | Initial | $29,499,978 | No comparison | 8 | SEC filing |
| Oct 29, 2019 | Initial | $7,020,664 | No comparison | 8 | SEC filing |
| Feb 20, 2018 | Initial | $3,229,337 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-391033
The Total Offering Amount and the Total Amount Sold includes the conversion of $4,000,000 of outstanding convertible securities.
Source: Form D, filed Mar 2, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Bensamoun | Director, Executive, Promoter |
| Stuart Ellman | Director |
| Andrea Hippeau | Director |
| Ronald Loren Kirkby | Director |
| Charles Murphy | Director |
Issuer details
Industry: Other (See others in industry)
Address:
215 Plymouth Street, 1 St Floor
Brooklyn, NY, 11201
Brooklyn, NY, 11201